Essential thrombocythemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

38Recruiting trials

Regulatory Watchboard

10 events

Jun 2026WELL-MPN: A Digital Lifestyle App for Patients With MPNs

Brigham and Women's Hospital — NA

TrialNOT YET RECRUITING

May 2026Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Novartis Pharmaceuticals — PHASE1

TrialNOT YET RECRUITING

May 2026Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

John Mascarenhas — PHASE2

TrialNOT YET RECRUITING

Apr 2026A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

Novartis Pharmaceuticals — PHASE3

TrialNOT YET RECRUITING

Apr 2026A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Prelude Therapeutics — PHASE1

TrialRECRUITING

Feb 2026Registry Platform Myelofibrosis and Anemia

iOMEDICO AG

TrialRECRUITING

Dec 2025A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

TrialRECRUITING

Oct 2025A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Incyte Corporation — PHASE1

TrialRECRUITING

Jun 2025A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essential Thrombocythaemia

Step Pharma, SAS — PHASE1

TrialRECRUITING

Feb 2025Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

GlaxoSmithKline — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

7 programs

FINANCIAL LANDSCAPE SUMMARY

7

Total programs

6

Open now

3

Copay cards

4

Travel grants

Copay Assistance3

FERRIPROX

Chiesi reinforcement _Self-correction:_ The user asked for the primary manufacturer/company that owns the rights. Chiesi is the entity. Final string: Chiesi

OpenContact for detailsApply ↗

Agrylin

Takeda

OpenContact for detailsApply ↗

Anagrelide

Takeda

OpenContact for detailsApply ↗

Travel Grants4

CancerCare Co-pay Assistance for Myeloproliferative Neoplasms

CancerCare

OpenContact for detailsApply ↗

Ferriprox Patient Enrollment (Chiesi USA)

Contact for detailsApply ↗

Takeda Here2Assist Program

Takeda Oncology

OpenContact for detailsApply ↗

Takeda Oncology Co-Pay Assistance Progam

Takeda Oncology

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Agrylin

(Anagrelide)Orphan drug

Takeda Development Center Americas, Inc.

12.1 Mechanism of Action The precise mechanism by which anagrelide reduces blood platelet count is unknown. In cell culture studies, anagrelide suppre...

Approved Mar 1997FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

38 active trials

6Phase 3

13Phase 2

3Phase 1

3N/A

8Unknown

5PHASE1, PHASE2

38Total recruiting

Search clinical trials for Essential thrombocythemia →

Recent News & Research

No recent news articles indexed yet for Essential thrombocythemia.
Search PubMed for Essential thrombocythemia →

Browse all Essential thrombocythemia news →

Specialist Network

Top 6 by expertise

Gabriela Hobbs, MD, MD

Massachusetts General Hospital

📍 BOSTON, MA

Score 384 trials1 pub

Naveen Pemmaraju, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 383 trials10 pubs

Naval Daver, MD, MBBS

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 308 trials

Srdan Verstovsek, MD, M.D., PhD

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 269 trials

Claire Harrison, Dr

St Thomas' Hospital

Score 251 trial

Anthony R Green, Prof

Addenbrooke's Hospital and University of Cambridge

Score 231 trial

View all Essential thrombocythemia specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles